Literature DB >> 2729050

Risk factors and noncontraceptive estrogen use in women with and without coronary disease.

K F McFarland1, M E Boniface, C A Hornung, W Earnhardt, J O Humphries.   

Abstract

To evaluate the risk factors for coronary disease, 345 women, aged 35 to 59 years, who had undergone coronary arteriography for suspected coronary disease completed a mail questionnaire, telephone interview, or both. Two hundred eight women with angiographically normal coronary arteries constituted the control group, and 137 with a 70% or more occlusion of one or more coronary vessels were classified as having severe coronary occlusive disease. Age-adjusted odds of severe coronary disease based on the logistic regression model for the risk factors evaluated were as follows: smoking, 5.73 (p less than 0.001); diabetes, 5.09 (p less than 0.001); cholesterol level greater than 240 mg/dl, 2.35 (p less than 0.05); a parental history of death from heart disease before age 60 years, 2.03 (p less than 0.05); and estrogen use for 6 months or longer, 0.50 (p less than 0.01). There were no differences with regard to the presence of obesity and a history of hypertension in women with and without coronary disease. These data support the hypothesis that use of noncontraceptive estrogen significantly reduces the risk of severe coronary disease, whereas smoking, an elevated cholesterol level, and a parental history of heart disease all increase the risk of ischemic heart disease in women.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729050     DOI: 10.1016/0002-8703(89)90398-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

Review 1.  Postmenopausal hormone replacement therapy.

Authors:  H S Jacobs; F E Loeffler
Journal:  BMJ       Date:  1992-12-05

Review 2.  Extraskeletal effects of estrogen and the prevention of atherosclerosis.

Authors:  T L Bush
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

Review 3.  Postmenopausal hormone replacement therapy and cardiovascular risk reduction. A review.

Authors:  S D Kafonek
Journal:  Drugs       Date:  1994       Impact factor: 9.546

Review 4.  Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins.

Authors:  M Seed
Journal:  Drugs       Date:  1994       Impact factor: 9.546

Review 5.  Sex steroids and the cardiovascular system.

Authors:  C Christiansen
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 6.  [Estrogens for prevention of coronary heart disease?].

Authors:  T Meinertz
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

7.  Coronary heart disease, the menopause, and hormone replacement therapy.

Authors:  I Findlay; D Cunningham; H J Dargie
Journal:  Br Heart J       Date:  1994-03

Review 8.  Sex hormones and vascular reactivity.

Authors:  S J Hutchison; K Sudhir; T M Chou; K Chatterjee
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

Review 9.  Postmenopausal hormone replacement therapy as antiatherosclerotic therapy.

Authors:  Howard N Hodis; Wendy J Mack; Roger Lobo
Journal:  Curr Atheroscler Rep       Date:  2002-01       Impact factor: 5.113

Review 10.  Trophic factors in aging. Should older people receive hormonal replacement therapy?

Authors:  D T Villareal; J E Morley
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.